Cargando…
Potential Roles of Antiphospholipid Antibodies in Generating Platelet-C4d in Systemic Lupus Erythematosus
Premature, accelerated onset of atherothrombotic disease is prevalent in patients with systemic lupus erythematosus (SLE). Most, if not all, atherothrombotic diseases are likely to involve platelets and complement. Previously, we discovered that platelets bearing complement activation product C4d (P...
Autores principales: | Liu, Chau-Ching, Schofield, Travis, Tang, Amy, Manzi, Susan, Ahearn, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698828/ https://www.ncbi.nlm.nih.gov/pubmed/31548524 http://dx.doi.org/10.3390/antib6030009 |
Ejemplares similares
-
IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022) -
Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023) -
An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
por: Hisada, Ryo, et al.
Publicado: (2023) -
Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023) -
Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)